Shandong Anxin Pharmaceutical Co., Ltd.
Shandong Anxin Pharmaceutical Co., Ltd. is one of the subsidiaries of Qilu Pharmaceutical Group. It is a modern technology enterprise integrating raw materials and preparation production, scientific research, and pharmaceutical R&D outsourcing. The products cover multiple fields such as anti-infection, tumor, cardiovascular, cerebrovascular, mental and nervous system, and have formed a complete industrial chain from raw materials to preparation products.
was founded in
28Ten thousand m²
"Top Ten National Brands of Export-oriented APIs"
The company’s drug research center was identified as the “one enterprise, one technology” research center in Shandong Province, and Jinan City Antibiotic Chemical Synthetic Drug Engineering Technology Research Center was also established.
Essence has a global marketing network, and has a win-win cooperation with many international pharmaceutical giants such as Pfizer, Novartis and Merck. The company's products are exported to more than 50 countries and regions around the world, benefiting 5.6 billion people, accounting for 73.8% of the world's population.
It has established a quality control and assurance system in line with international standards. Many series of products have passed the certification of the World Health Organization, the United States, the United Kingdom, Germany, Japan, South Africa and other countries and organizations. Recognition by the drug certification officer.
Product export countries and regions
Benefit the population
Of the world's population
Global freeze-dried API capacity
Shandong Anxin Pharmaceutical Co., Ltd. and the People's Government of Licheng District, Jinan City, signed a letter of responsibility for soil control
The first public announcement of the environmental impact assessment of the 1500m³d wastewater treatment expansion project
Emergency drill for on-site handling of environmental emergencies